NCT06037512Completed
User Evaluation of BGM VGM77
Evaluierung Des Blutglukose Monitoring Systems VGM77 Der Firma Beurer GmbH gemäß DIN EN ISO 15197:2015
Institut fur Diabetes Karlsburg GmbHClinicalTrials.govdiagnostic test
Study focus
- Disease/Condition
- Diabetes
- Drug/Device/Intervention
- subject
- Study type
- Interventional
- Intervention type
- diagnostic test
Sponsor & location
- Primary sponsor
- Institut fur Diabetes Karlsburg GmbH
- Location
- Karlsburg, Germany
Timeline & enrollment
- Phase
- N/A
- Start date
- Apr 13, 2023
- End date
- Jun 15, 2023
- Enrollment
- 106 participants
Primary outcome
Analysis of system accuracy based on DIN EN ISO 15197
Summary
Performance Evaluation by the User of the Blood Glucose Monitoring System VGM77Compliant with
 DIN EN ISO 15197:2015
ICD-10 classifications
Diabetes mellitusUnspecified diabetes mellitusOther specified diabetes mellitusUnspecified diabetes mellitus without complicationsOther specified diabetes mellitus without complications
Data source
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06037512
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for NCT06037512 through Pure Global AI's free database. This phase not specified trial is sponsored by Institut fur Diabetes Karlsburg GmbH and is currently Completed. The study focuses on Diabetes. Target enrollment is 106 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.